Jefferies reaffirmed a buy rating on Novavax shares, amidst discussions regarding potential updates to COVID-19 vaccines and FDA considerations.
4 reports, 2 independent
Updated Jul 8
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 4
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Jefferies reaffirmed a buy rating on Novavax shares, amidst discussions regarding potential updates to COVID-19 vaccines and FDA considerations.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Jefferies reaffirmed buy rating on Novavax shares as advisers consider COVID-19 vaccine updates.1 source
TD Cowen adjusted price targets and ratings for Novavax, joining Jefferies' buy rating.1 source
Keep exploring
The entities involved
-
Novavax
company in Gaithersburg, Maryland
Nothing else this week.
-
Jefferies Financial Group
American financial services company
- FDA
Related events
- Jefferies Financial Group restated a buy rating on Wise shares.
- Allegro MicroSystems stock is trading on the Nasdaq exchange, and Jefferies Financial Group has issued a buy rating, while MarketBeat aggregates consensus ratings.
- Jefferies Financial Group started coverage and issued a buy rating on Cameco.
- Jefferies Financial Group reiterated a buy rating on Chrysalis Investments shares on October 1, 2026.
- Jefferies Financial Group upgraded Reckitt's stock rating to 'buy' on October 11, 2026.